retatrutide works (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it Retatrutide: Triple-Action Weight Loss Peptide

The mechanism of GLP-1 agonists involves slowing gastric emptying, which prolongs the feeling of fullness after eating and, in turn, tends to reduce the frequency of eating

Scroll down for the full step-by-step guide, common mistakes to avoid, and answers to the most frequently asked questions

Possible side effects Nausea Diarrhea Decreased appetite Vomiting Constipation Dyspepsia (indigestion) Abdominal pain If side effects are severe or persistent, contact your healthcare provider

Ready for a Transformation

GLP-1 Medications Compare Ozempic, Wegovy, Mounjaro, and more

The Need for More Research in the GLP1 Era Despite growing anecdotal reports, the sensory-related side effects of GLP1s remain largely under-researched